American CryoStem Corporation and XeoStem LLC Complete Adipose Stem Cell Processing and Tissue Banking Agreement
November 27 2012 - 2:16PM
American CryoStem Corporation (OTCQB:CRYO), a leading biotech
company in the Regenerative Medicine industry, announced today that
it has entered into an agreement with XeoStem LLC of Coral Gables,
FL in which CRYO will provide its proprietary adipose tissue
processing and storage services. The initial agreement allows
XeoStem to market CRYO's adipose tissue platform, stem cell
processing services, patented products and banking technology for
tissue grafting and "bio-insurance" purposes to their patients and
groups of physicians.
"American CryoStem's proprietary platform is designed to service
individual physicians and large physician networks like XeoStem
offering Regenerative Medicine services. We continually strive to
work with leading medical professionals and organizations
developing cellular therapies and related services," stated John
Arnone, CEO of American CryoStem. "This is one of many strategic
opportunities to leverage our technology and augment our direct to
consumer and physician marketing efforts."
Additionally XeoStem operates a dedicated management company,
XeoStem MD, for recruiting and training physicians on the latest
tissue transfer techniques, banking and adult stem cell
applications. Under the agreement, all XeoStem branded services
will include the tagline "Processed by American CryoStem."
"XeoStem incorporates the latest web technology, print, social
media marketing techniques and educational seminars to facilitate
access and adoption of our services," stated Dr. Abuzeni, CEO of
XeoStem. "We are focused on the overall patient and physician
experience, and have developed web-applications specifically
designed to inform our network concerning the latest Regenerative
Medicine advancements."
About XeoStem: XeoStem, LLC was founded by Dr. Patrick Abuzeni
to deliver adipose tissue and stem cell services and practical
knowledge to patients and affiliated physicians. XeoStem believes
that stem cells have the potential of transforming the future of
medicine in cosmetic, orthopedic and disease management
applications. XeoStem has partnered with American CryoStem, a
leader in processing and biological banking of Adipose (fat) tissue
and Adult Adipose Derived Stem Cells to provide the highest
quality, reliable and economic adipose tissue and stem cell
processing and storage.
About American CryoStem: American CryoStem Corporation
(OTCQB:CRYO) is a leading biotech company focused on marketing its
clinical processing services and patented products for adipose
(fat) tissue and adipose derived adult stem cells. Our clinical
tissue processing, patented cell culture media products and tissue
storage platform supports cosmetic and Regenerative Medicine
applications being developed globally. The Company provides high
quality, clinically processed viable cells, while at the same time
developing cutting edge applications, therapies, patented
laboratory products and services for consumer and commercial
applications.
CONTACT: Investor Relations Contact:
American CryoStem Corporation
732-747-1007
info@americancryostem.com
www.americancryostem.com
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jun 2024 to Jul 2024
American Cryostem (CE) (USOTC:CRYO)
Historical Stock Chart
From Jul 2023 to Jul 2024